BISI International Tbk vs UBC Medical Indonesia Tbk. — how do they compare? BISI International Tbk trades at Rp635 (market cap 1.91T, 228.6K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: BISI International Tbk is far larger — about 3.3× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (1.44M versus 228.6K). Which is the better fit depends on your goals.
| BISI | LABS | |
|---|---|---|
Market Cap | 1.91T | 584.6B |
Volume | 228.6K | 1.44M |
Lot | 2.29K | 14.4K |
Turnover | 144.03M | 209.72M |
Average Price | 630.04 | 145.64 |
Value | 144.03M | 209.72M |
Indicative Equilibrium Price | 635 | 146 |
Indicative Equilibrium Volume | 20 | 753 |
Trailing returns across standard periods
Latest headlines on both assets
Bisi International, PT (the Company) was established under its original name of PT Benihinti Suburintani on Jun 22, 1983 under the rules of the Foreign Capital Investment (PMA). The main activities of the company are production dan trade seed of corn, vegetables and rice. The Company name then changed to PT BISI International based on Notaries Deed dated Oct 3, 2006 and the deed of establishment was approved by the the Ministry of Justice dated Nov 6, 2006. The company was located at Sidoarjo, Jawa Timur. Plantation and production facilities were located at Desa Sumber Agung, Kec Ploso Klaten, Kab Kediri. The latest amendment of the Articles of Association was registered through Notary Deed No. 3 dated March 1, 2007 of Henny Singgih, SH, to comply with the Corporate Law No. 8 thn 1995. The amendment includes, among others, par value of share.
Read more on BISI →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →